SSGJ-707

New Business

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by…

Read More »
New Business

Chinese biotech firm secures US$6 billion Pfizer deal for cancer drug

Chinese drug maker 3SBio has licensed its new cancer drug to US pharmaceutical giant Pfizer in the largest deal ever…

Read More »
Back to top button